These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 14692723

  • 1. Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial.
    Gastpar M, Klimm HD.
    Phytomedicine; 2003 Nov; 10(8):631-9. PubMed ID: 14692723
    [Abstract] [Full Text] [Related]

  • 2. Kava treatment in patients with anxiety.
    Geier FP, Konstantinowicz T.
    Phytother Res; 2004 Apr; 18(4):297-300. PubMed ID: 15162364
    [Abstract] [Full Text] [Related]

  • 3. Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial.
    Volz HP, Kieser M.
    Pharmacopsychiatry; 1997 Jan; 30(1):1-5. PubMed ID: 9065962
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines.
    Malsch U, Kieser M.
    Psychopharmacology (Berl); 2001 Sep; 157(3):277-83. PubMed ID: 11605083
    [Abstract] [Full Text] [Related]

  • 5. [Effect of a special kava extract in patients with anxiety-, tension-, and excitation states of non-psychotic genesis. Double blind study with placebos over 4 weeks].
    Kinzler E, Krömer J, Lehmann E.
    Arzneimittelforschung; 1991 Jun; 41(6):584-8. PubMed ID: 1930344
    [Abstract] [Full Text] [Related]

  • 6. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S, Volz HP, Möller HJ, Dienel A, Kieser M.
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial.
    Kalb R, Trautmann-Sponsel RD, Kieser M.
    Pharmacopsychiatry; 2001 May; 34(3):96-103. PubMed ID: 11434406
    [Abstract] [Full Text] [Related]

  • 8. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.
    Sarris J, Stough C, Bousman CA, Wahid ZT, Murray G, Teschke R, Savage KM, Dowell A, Ng C, Schweitzer I.
    J Clin Psychopharmacol; 2013 Oct; 33(5):643-8. PubMed ID: 23635869
    [Abstract] [Full Text] [Related]

  • 9. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H, Raassina R, Penttinen J, Ahokas A, Jokinen R, Koponen H, Lepola U, Kanerva H, Lehtonen L, Pohjalainen T, Partanen A, Mäki-Ikola O, Rouru J, Deramciclane Dose-Finding Study Group.
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [Abstract] [Full Text] [Related]

  • 10. Clinical efficacy of kava extract WS 1490 in sleep disturbances associated with anxiety disorders. Results of a multicenter, randomized, placebo-controlled, double-blind clinical trial.
    Lehrl S.
    J Affect Disord; 2004 Feb; 78(2):101-10. PubMed ID: 14706720
    [Abstract] [Full Text] [Related]

  • 11. The special extract ERr 731 of the roots of Rheum rhaponticum decreases anxiety and improves health state and general well-being in perimenopausal women.
    Kaszkin-Bettag M, Ventskovskiy BM, Kravchenko A, Rettenberger R, Richardson A, Heger PW, Heger M.
    Menopause; 2007 Feb; 14(2):270-83. PubMed ID: 17213754
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 13. Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study.
    Andreatini R, Sartori VA, Seabra ML, Leite JR.
    Phytother Res; 2002 Nov; 16(7):650-4. PubMed ID: 12410546
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of a standardized herbal product from Galphimia glauca on generalized anxiety disorder. A randomized, double-blind clinical trial controlled with lorazepam.
    Herrera-Arellano A, Jiménez-Ferrer E, Zamilpa A, Morales-Valdéz M, García-Valencia CE, Tortoriello J.
    Planta Med; 2007 Jul; 73(8):713-7. PubMed ID: 17562493
    [Abstract] [Full Text] [Related]

  • 15. Kava-Kava extract LI 150 is as effective as Opipramol and Buspirone in Generalised Anxiety Disorder--an 8-week randomized, double-blind multi-centre clinical trial in 129 out-patients.
    Boerner RJ, Sommer H, Berger W, Kuhn U, Schmidt U, Mannel M.
    Phytomedicine; 2003 Jul; 10 Suppl 4():38-49. PubMed ID: 12807341
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of orally administered Silexan in patients with anxiety-related restlessness and disturbed sleep--A randomized, placebo-controlled trial.
    Kasper S, Anghelescu I, Dienel A.
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):1960-7. PubMed ID: 26293583
    [Abstract] [Full Text] [Related]

  • 17. [Psychosomatic dysfunctions in the female climacteric. Clinical effectiveness and tolerance of Kava Extract WS 1490].
    Warnecke G.
    Fortschr Med; 1991 Feb 10; 109(4):119-22. PubMed ID: 2029982
    [Abstract] [Full Text] [Related]

  • 18. Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study.
    Anghelescu IG, Kohnen R, Szegedi A, Klement S, Kieser M.
    Pharmacopsychiatry; 2006 Nov 10; 39(6):213-9. PubMed ID: 17124643
    [Abstract] [Full Text] [Related]

  • 19. Effects of treatment with etizolam 0.5 mg BID on cognitive performance: a 3-week, multicenter, randomized, double-blind, placebo-controlled, two-treatment, three-period, noninferiority crossover study in patients with anxiety disorder.
    De Candia MP, Di Sciascio G, Durbano F, Mencacci C, Rubiera M, Aguglia E, Garavini A, Bersani G, Di Sotto A, Placidi G, Cesana BM.
    Clin Ther; 2009 Dec 10; 31(12):2851-9. PubMed ID: 20110024
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
    Lizogub VG, Riley DS, Heger M.
    Explore (NY); 2007 Dec 10; 3(6):573-84. PubMed ID: 18005909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.